A Dose Escalation Trial of Stereotactic Body Radiotherapy (SBRT) After Induction Chemotherapy for Locally Advanced Pancreatic Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

December 16, 2024

Study Completion Date

December 16, 2024

Conditions
Pancreatic Cancer
Interventions
RADIATION

Stereotactic Body Radiotherapy (SBRT)

Trial Locations (7)

10065

Memorial Sloan Kettering Cancer Center, New York

10604

Memorial Sloan Kettering Westchester (Consent and follow-up only), Harrison

11725

Memorial Sloan Kettering Commack (Consent and follow-up only), Commack

07920

Memorial Sloan Kettering Basking Ridge (Consent and follow-up only), Basking Ridge

07748

Memorial Sloan Kettering Monmouth (Consent and follow-up only), Middletown

07645

Memorial Sloan Kettering Bergen (Consent and follow-up only), Montvale

Unknown

Memorial Sloan Kettering Nassau (Consent and Follow-up), Rockville Centre

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT02643498 - A Dose Escalation Trial of Stereotactic Body Radiotherapy (SBRT) After Induction Chemotherapy for Locally Advanced Pancreatic Cancer | Biotech Hunter | Biotech Hunter